Yoshihisa Kobayashi

The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity.

Takayuki Fukui, Y. Yatabe, T. Mitsudomi, 2014, Lung cancer.

Efficacy of irreversible EGFR-TKIs for the uncommon secondary resistant EGFR mutations L747S, D761Y, and T854A

Masato Terashima, Kazuko Sakai, Kazuto Nishio, 2017, BMC Cancer.

Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy

Junichi Shimizu, Toyoaki Hida, Jangchul Park, 2013, Cancer medicine.

EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs

Kenichi Suda, Masaki Shimoji, Toyoaki Hida, 2015, Clinical Cancer Research.

Not all epidermal growth factor receptor mutations in lung cancer are created equal: Perspectives for individualized treatment strategy

T. Mitsudomi, Yoshihisa Kobayashi, Tetsuya Mitsudomi, 2016, Cancer science.

Management of ground-glass opacities: should all pulmonary lesions with ground-glass opacity be surgically resected?

T. Mitsudomi, Yoshihisa Kobayashi, Tetsuya Mitsudomi, 2013, Translational lung cancer research.